Chan Kim
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- interferon and immune responses
Papers in
- Co-authors
- Hong Jae Chon (65 shared papers)Hannah Yang (30 shared papers)Won Suk Lee (27 shared papers)Sun Young Rha (24 shared papers)So Jung Kong (14 shared papers)Hyun Cheol Chung (16 shared papers)Joong Bae Ahn (11 shared papers)Beodeul Kang (35 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Cancer Research (8 papers)Cancer Research and Treatment (7 papers)BMC Cancer (5 papers)Journal for ImmunoTherapy of Cancer (4 papers)
- Partner nations
- South KoreaUnited StatesSwitzerland
In The Last Decade
Chan Kim
171 papers receiving 4.2k citations
Chan Kim's Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 1.4k
- Immunology 936
- Cancer Research 502
- Hepatology 205
- Geriatrics and Gerontology 71
Countries citing papers authored by Chan Kim
This map shows the geographic impact of Chan Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chan Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chan Kim more than expected).
Fields of papers citing papers by Chan Kim
This network shows the impact of papers produced by Chan Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chan Kim. The network helps show where Chan Kim may publish in the future.
Co-authors
The 25 scholars most cited alongside Chan Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 181 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity Hit paper breakdown → | 2020 | 464 |
| 2 | 2016 | 270 | |
| 3 | 2019 | 254 | |
| 4 | 2016 | 176 | |
| 5 | 2020 | 139 | |
| 6 | 2018 | 135 | |
| 7 | 2016 | 128 | |
| 8 | 2016 | 122 | |
| 9 | 2016 | 118 | |
| 10 | 2014 | 114 | |
| 11 | 2014 | 112 | |
| 12 | 2011 | 86 | |
| 13 | 2021 | 83 | |
| 14 | 2019 | 65 | |
| 15 | 2021 | 63 | |
| 16 | 2017 | 61 | |
| 17 | 2009 | 59 | |
| 18 | 2020 | 52 | |
| 19 | 2020 | 50 | |
| 20 | 2023 | 50 |
About Chan Kim
Chan Kim is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Molecular Biology, having authored 181 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Spine and Intervertebral Disc Pathology (11 papers), Ferroptosis and cancer prognosis (11 papers), Virus-based gene therapy research (9 papers), Trigeminal Neuralgia and Treatments (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Gastric Cancer Management and Outcomes (8 papers). The work is most often cited by research in Oncology (1.4k citations), Immunology (936 citations), Cancer Research (502 citations), Hepatology (205 citations) and Geriatrics and Gerontology (71 citations). Chan Kim has collaborated with scholars based in South Korea, United States and Switzerland. Frequent co-authors include Hong Jae Chon, Hannah Yang, Won Suk Lee, Sun Young Rha, So Jung Kong, Hyun Cheol Chung, Joong Bae Ahn, Beodeul Kang, Joo Hoon Kim and Gou Young Koh. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Cancer Research and Treatment, BMC Cancer and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.